3-aminoisobutyric acid has been researched along with quetiapine fumarate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuyama, K; Motomura, E; Okada, M | 1 |
1 other study(ies) available for 3-aminoisobutyric acid and quetiapine fumarate
| Article | Year |
|---|---|
A Candidate Gliotransmitter, L-β-Aminoisobutyrate, Contributes to Weight Gain and Metabolic Complication Induced by Atypical Antipsychotics.
Topics: AMP-Activated Protein Kinases; Antipsychotic Agents; Body Weight; Humans; Lurasidone Hydrochloride; Quetiapine Fumarate; Weight Gain | 2023 |